Tag: safety pharmacology
-
Preclinical Development and IND/CTA Readiness: making the candidate safe enough to test in people
This is Part 4 of The Drug Development Playbook. We talk about building nonclinical and CMC evidence that lets regulators say yes to first-in-human trials.
-
Hit Discovery and Lead Optimization – how teams turn a validated target into an actual drug candidate
This is Part 3 of The Drug Development Playbook. We answer the next question: how do you find molecules that not only hit that biology but can become safe, manufacturable medicines?
Aryan Kenia 